Some observations on psilocybin, a new hallucinogen, in volunteer subjects.

Abstract

Abstract 14 paid volunteers, screened by interview, received psilocybin orally over a dosage range of 8-36 mg. Except for a greater impairment of cognition with psilocybin, the results including EEG were similar to those previously reported with d-LSD-25. The use of …